Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304369 · ClinicalTrials.gov registry record
Response of Clostridium Difficile Infection to Metronidazole Therapy
A clinical trial, sponsored by Michael E. DeBakey VA Medical Center.
- Completed
- Registry status
- 290
- Enrollment target
NCT00304369 is a clinical trial that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 290 participants.
The verdict
NCT00304369 has completed, sponsored by Michael E. DeBakey VA Medical Center.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.
Interventions
- DRUG Metronidazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00304369
The ClinicalTrials.gov registry entry for NCT00304369 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael E. DeBakey VA Medical Center, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metronidazole is the first listed.
NCT00304369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00304369 about?
NCT00304369 is a clinical study titled "Response of Clostridium Difficile Infection to Metronidazole Therapy". In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.
What is the current status of trial NCT00304369?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2005-06. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00304369?
The interventions under investigation include: Metronidazole (DRUG).
Who is sponsoring clinical trial NCT00304369?
This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.